| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2013 | US8461161 Substituted pyrazines as inhibitors of kinase activity |
| 06/11/2013 | US8461160 Dihydropyrimidinones |
| 06/11/2013 | US8461159 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 06/11/2013 | US8461158 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 06/11/2013 | US8461157 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 06/11/2013 | US8461156 Modulators of ATP-binding cassette transporters |
| 06/11/2013 | US8461155 Binding to LRP5 or LRP6 receptor; promoting growth with DAN family bone morphogenetic protein antagonist |
| 06/11/2013 | US8461154 Methods of utilizing arylpiperazine derivatives |
| 06/11/2013 | US8461153 Benzodiazepinone compounds useful in the treatment of skin conditions |
| 06/11/2013 | US8461152 Arylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 06/11/2013 | US8461151 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
| 06/11/2013 | US8461150 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 06/11/2013 | US8461149 Compounds useful as protein kinase inhibitors |
| 06/11/2013 | US8461148 Use of memantine (namenda) to treat autism, compulsivity and impulsivity |
| 06/11/2013 | US8461147 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2013 | US8461146 Pharmaceutical composition for the treatment of premature ejaculation |
| 06/11/2013 | US8461145 Dibenzoazepine and dibenzooxazepine TRPA1 agonists |
| 06/11/2013 | US8461144 Substituted isoquinoline and isoquinolinone derivatives |
| 06/11/2013 | US8461143 Stabilizing compositions for antibiotics and methods of use |
| 06/11/2013 | US8461142 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 06/11/2013 | US8461141 Preventive or therapeutic drug for Alzheimer-type dementia |
| 06/11/2013 | US8461140 Synthetic bile acid compositions and methods |
| 06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
| 06/11/2013 | US8461138 Quadraphasis continuous graduated estrogen contraceptive |
| 06/11/2013 | US8461137 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 06/11/2013 | US8461136 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 06/11/2013 | US8461135 Boron-containing small molecules as anti-inflammatory agents |
| 06/11/2013 | US8461134 Boron-containing small molecules |
| 06/11/2013 | US8461133 Inclusion complexes containing an active substance, a cyclodextrin and an agent for interaction |
| 06/11/2013 | US8461131 Composition containing fermantable polysaccharides |
| 06/11/2013 | US8461130 Food containing glycogen and use thereof |
| 06/11/2013 | US8461129 Carboxyalkylated polysaccharides comprising a biobased content for use in diapers, incontinence articles, feminine hygiene, print , textile, absorbent paper and bandage products |
| 06/11/2013 | US8461128 Anti-microbial agents and uses thereof |
| 06/11/2013 | US8461126 Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions |
| 06/11/2013 | US8461124 Five- and six-membered conformationally locked 2′,4′-carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 06/11/2013 | US8461123 Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| 06/11/2013 | US8461122 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 06/11/2013 | US8461121 Macrolide synthesis process and solid-state forms |
| 06/11/2013 | US8461120 Macrocyclic compounds pounds and methods of use thereof |
| 06/11/2013 | US8461102 Methods and compositions for treating and preventing symptoms of hormonal variations |
| 06/11/2013 | US8461101 Targeting PAX2 for the treatment of breast cancer |
| 06/11/2013 | US8461086 Microcapsule composition for inhibiting an ethylene response in plants, method for preparing microcapsules, and method using the microcapsule composition |
| 06/11/2013 | US8461083 Herbicidal compounds |
| 06/11/2013 | US8461078 Fungicidal compositions including hydrazone derivatives and copper |
| 06/11/2013 | US8460939 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 06/11/2013 | US8460867 Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene |
| 06/11/2013 | US8460709 Pharmaceutical microparticles |
| 06/11/2013 | US8460707 Stabilised prostaglandin composition |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | US8460705 Threo-DOPS controlled release formulation |
| 06/11/2013 | US8460704 Extended release formulation of nevirapine |
| 06/11/2013 | US8460693 prosthesis, shunt, catheter or local drug delivery device with coating of a biocompatible oil or fat containing a therapeutic agent; e.g. cod liver oil or olive oil and alpha-tocopherol |
| 06/11/2013 | US8460689 Oral care method and kit |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460665 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 06/11/2013 | US8460646 Methods and compositions for treating mammalian nerve tissue injuries |
| 06/11/2013 | US8460644 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 06/11/2013 | US8460642 Boldline compounds for promoting bone growth |
| 06/11/2013 | US8460641 Microemulsion process and composition |
| 06/11/2013 | CA2730511C 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/11/2013 | CA2725704C Industrial process for preparing tropenol |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2706357C 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease |
| 06/11/2013 | CA2690488C Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 06/11/2013 | CA2683453C Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof |
| 06/11/2013 | CA2672985C Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 06/11/2013 | CA2665949C Vinca alkaloid antimitotic halogenated derivatives |
| 06/11/2013 | CA2646974C Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 06/11/2013 | CA2627498C Compositions and methods for improving skin health and pelage quality |
| 06/11/2013 | CA2601427C A method and composition for nutritionally improving glucose control and insulin action |
| 06/11/2013 | CA2600773C Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis |
| 06/11/2013 | CA2585112C Fused pyrimidines and their use as inhibitors of pi3k |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/11/2013 | CA2576832C Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
| 06/11/2013 | CA2576393C Novel derivatives of 3,5-seco-4-norcholestane and use thereof |
| 06/11/2013 | CA2572218C Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 06/11/2013 | CA2570916C Pulsed release dosage form of a ppi |
| 06/11/2013 | CA2562617C (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents |
| 06/11/2013 | CA2559700C Benzoxazine for treating respiratory tract diseases |
| 06/11/2013 | CA2559161C Irna agents targeting vegf |
| 06/11/2013 | CA2554463C Anti-cancer therapies |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/11/2013 | CA2541869C Compositions and methods for use in targeting vascular destruction |
| 06/11/2013 | CA2538857C Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 06/11/2013 | CA2533690C Use of a polyamine-poor composition for the production of a medical human food |
| 06/11/2013 | CA2523203C Novel phosphonic acid compounds as inhibitors of serine proteases |
| 06/11/2013 | CA2523021C Improved extraction and purification method for cereal beta-glucan |
| 06/11/2013 | CA2519418C New injectable formulations containing progesterone |
| 06/11/2013 | CA2504255C The local administration of a combination of sirolimus and 2-methoxyestradiol for the treatment of vulnerable plaque |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2473864C Composition for use in treating patients suffering from movement disorder |
| 06/11/2013 | CA2473158C Treatment of rheumatoid arthritis using imatinib |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2436832C Crystal form of a cyclic depsipeptide having improved activity |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2406277C Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |